**Analgesic Agents: NSAIDS**

| Criteria 1 | NP - Diclofenac/Misoprostol, Diclofenac Gel 3%, Diclofenac Patch 1.3%, Diclotrex, Elyxyb, Fenoprofen 400mg, Ibuprofen/Famotidine, Ketorolac Tromethamine Nasal Spray, Ketoprofen, Licart Patch, Meloxicam Cap, Naproxen CR, Naproxen DR, Naproxen ER, Naproxen EC, Naproxen/Esomeprazole, Qmiiz ODT, Relafen DS, Zorvolex |
| ---------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Criteria 2 | NP- Pennsaid (NP, BvG), Diclofenac Soln                                                                                                                                                                                                                                                                                   |
| Criteria 3 | Naproxen Susp (P, AR)                                                                                                                                                                                                                                                                                                     |

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: NSAIDS</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred Products</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>DICLOFENAC/MISOPROSTOL</td>
<td>020279</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DICLOFENAC/MISOPROSTOL</td>
<td>035737</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DICLOFENAC GEL 3%</td>
<td>039826</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DICLOFENAC PATCH 1.3%</td>
<td>062176</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DICLOFENAC SOLN 1.5%</td>
<td>051971</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DICLOFENAC POTASSIUM</td>
<td>021380</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DICLOTREX</td>
<td>081406</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ELYXYB</td>
<td>081009</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENOPROFEN 400 mg</td>
<td>065880</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>IBUPROFEN/FAMOTIDINE</td>
<td>067901</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>KETOROLAC TROMETHAMINE NASAL SPRAY</td>
<td>067386</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>KETOPROFEN</td>
<td>008379</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>KETOPROFEN</td>
<td>008380</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>LICART PATCH</td>
<td>079402</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MELOXICAM CAP</td>
<td>075207</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MELOXICAM CAP</td>
<td>075208</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NAPROXEN CR, DR, ER, EC</td>
<td>018435</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>NAPROXEN CR, DR, ER, EC</td>
<td>018436</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NAPROXEN CR, DR, ER, EC</td>
<td>044257</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>NAPROXEN CR, DR, ER, EC</td>
<td>063142</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NAPROXEN CR, DR, ER, EC</td>
<td>064693</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>NAPROXEN/ESOMEPRAZOLE</td>
<td>066328</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NAPROXEN/ESOMEPRAZOLE</td>
<td>066329</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OMIIZ ODT</td>
<td>073318</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OMIIZ ODT</td>
<td>079274</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>RELAFEN DS</td>
<td>041308</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ZORVOLEX</td>
<td>071599</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ZORVOLEX</td>
<td>071600</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1 </td>
<td>0998</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>0999</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1233</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0999</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y </td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>3</td>
<td>1000 </td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">30 days</span> with at least <span class="underline">two preferred</span> drugs?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1001</td>
</tr>
<tr class="odd">
<td>4</td>
<td>1001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y   </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N   </td>
<td>1236 </td>
</tr>
<tr class="odd">
<td>5</td>
<td>1002</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1004</td>
</tr>
<tr class="odd">
<td>6</td>
<td>1003</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e., medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1004</td>
<td></td>
<td>Select</td>
<td>What is the patient’s diagnosis?</td>
<td>H. Pylori Treatment</td>
<td>END (Approve x 30 Days)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Transdermal/Topical</td>
<td>END (Approve x 90 Days)  </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>END (Approve x 365 Days)  </td>
</tr>
<tr class="even">
<td>8</td>
<td>1233</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</td>
<td> Y    </td>
<td>1234  </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="even">
<td>9</td>
<td>1234</td>
<td></td>
<td>Select</td>
<td>What is the patient’s diagnosis?</td>
<td>H. Pylori Treatment</td>
<td>END (Approve x 30 Days)  </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Transdermal/Topical</td>
<td>END (Approve x 90 Days)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>END (Approve x 365 days)  </td>
</tr>
<tr class="odd">
<td>10</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>11</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: H. Pylori Treatment 30 days,
Transdermal/Topical 90 days, All Other Treatments 365 days

| **Last Approved ** | 8/22/2023 |
| ------------------ | --------- |
| **Other**          |           |

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: NSAIDs</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Pennsaid</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>PENNSAID</td>
<td>071910</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DICLOFENAC SOLN</td>
<td>071910</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1 </td>
<td>0998</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>0999</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1233</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0999</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y </td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>3</td>
<td>1000 </td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">30 days</span> with at least <span class="underline">two preferred</span> drugs?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1001</td>
</tr>
<tr class="odd">
<td>4</td>
<td>1001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y   </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N   </td>
<td>1236 </td>
</tr>
<tr class="odd">
<td>5</td>
<td>1002</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1004</td>
</tr>
<tr class="odd">
<td>6</td>
<td>1003</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1004</td>
<td></td>
<td>Select</td>
<td>Is the request for any of the following agents: Brand Pennsaid, generic diclofenac soln?</td>
<td>Y</td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1007</td>
</tr>
<tr class="odd">
<td>8</td>
<td>1005</td>
<td></td>
<td>Select</td>
<td>Which medication is being requested?</td>
<td>Brand Pennsaid</td>
<td>1007</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Generic diclofenac soln</td>
<td>1006</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>1235</td>
</tr>
<tr class="even">
<td>9</td>
<td>1006</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the brand medication been attempted and failed or is the brand medication contraindicated?  </p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>1007</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>10</td>
<td>1007</td>
<td></td>
<td>Select</td>
<td>What is the patient’s diagnosis?</td>
<td>H. Pylori Treatment</td>
<td>END (Approve x 30 Days)  </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Transdermal/Topical</td>
<td>END (Approve x 90 Days)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>END (Approve x 365 Days)  </td>
</tr>
<tr class="odd">
<td>11</td>
<td>1233</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</td>
<td> Y    </td>
<td>1234  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>12</td>
<td>1234</td>
<td></td>
<td>Select</td>
<td>What is the patient’s diagnosis?</td>
<td>H. Pylori Treatment</td>
<td>END (Approve x 30 Days)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Transdermal/Topical</td>
<td>END (Approve x 90 Days)  </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>END (Approve x 365 Days)  </td>
</tr>
<tr class="even">
<td>13</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="odd">
<td>14</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: H. Pylori Treatment 30 days,
Transdermal/Topical 90 days, All Other Treatments 365 days

| **Last Approved ** | 8/22/2023 |
| ------------------ | --------- |
| **Other**          |           |

**  
**

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: NSAIDs</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Naproxen Susp</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>NAPROXEN SUSP</td>
<td>008359</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1 </td>
<td>1234</td>
<td></td>
<td><p>Select   </p>
<p> </p></td>
<td><p>Is the patient 12 years old and older?   </p>
<p>Please note: a PA is only required for patients 12 years old and older.</p></td>
<td>Y   </td>
<td>1235</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N   </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>2</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>3</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>A PA is not required for those younger than 12 years of age.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: H. Pylori Treatment 30 days,
Transdermal/Topical 90 days, All Other Treatments 365 days

| **Last Approved ** | 8/22/2023 |
| ------------------ | --------- |
| **Other**          |           |
